Zoetis ZTS
NYSE ZTS
$75.58 -1.10 (-1.43%)
At close: Aug 20, 2026 · 10:49 AM UTC

Zoetis (ZTS) Net Margin (2012 - 2026)

Zoetis (ZTS) posted quarterly Net Margin of 26.57% for Q1 2026, down 82.0% year-over-year from 147.61% in Q1 2025, and up 5.18% quarter-over-quarter from 25.26% in Q4 2025.

Zoetis (ZTS) Net Margin (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Net Margin for 15 consecutive years, with 26.57% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Net Margin fell 82.0% year-over-year to 26.57%; the TTM figure through Mar 2026 stood at 27.79% (up 82.0% YoY), while the FY2025 annual figure was 28.23%, up 127.0% from the prior year.
  • Net Margin advanced to 26.57% in Q1 2026 per ZTS's latest filing, from 25.26% in the prior quarter.
  • Across five years, Net Margin topped out at 30.73% in Q2 2023 and bottomed at 22.55% in Q4 2022.
  • Historically, Net Margin has averaged 27.09% across 5 years, with a median of 27.35% in 2024.
  • Annual changes were most pronounced in 2023 — Net Margin soared 495 bps — and 2024, when it plunged 430 bps.
  • Zoetis' Net Margin stood at 22.55% in 2022, then climbed by 5 bps to 23.63% in 2023, then rose by 6 bps to 25.08% in 2024, then rose by 1 bps to 25.26% in 2025, then climbed by 5 bps to 26.57% in 2026.
  • Business Quant data shows ZTS's Net Margin at 26.57% in Q1 2026, 25.26% in Q4 2025, and 30.04% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 43.65 Bn 42.68 Bn - -
2 Teva Pharmaceutical Industries 43.09 Bn 39.44 Bn 2.15 Bn -13.91%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 9.28%
5 United Therapeutics 22.11 Bn 19.45 Bn 683.80 Mn 42.51%
6 Viatris 18.77 Bn 17.88 Bn 1.46 Bn -3.16%
7 Neurocrine Biosciences 15.62 Bn 15.23 Bn 935.80 Mn 15.06%
8 Elanco Animal Health 12.07 Bn 11.54 Bn 798.00 Mn 3.95%
9 Dr Reddys Laboratories 10.09 Bn 9.93 Bn - -
10 Alkermes 8.20 Bn 7.54 Bn 397.90 Mn 0.11%

Historic Data

Download Data
DateValue
Jun 30, 2026 28.00%
Mar 31, 2026 26.57%
Dec 31, 2025 25.26%
Sep 30, 2025 30.04%
Jun 30, 2025 29.19%
Mar 31, 2025 27.39%
Dec 31, 2024 25.08%
Sep 30, 2024 28.98%
Jun 30, 2024 26.43%
Mar 31, 2024 27.35%
Dec 31, 2023 23.63%
Sep 30, 2023 27.71%
Jun 30, 2023 30.73%
Mar 31, 2023 27.55%
Dec 31, 2022 22.55%
Sep 30, 2022 26.37%
Jun 30, 2022 25.78%
Mar 31, 2022 29.91%
Dec 31, 2021 21.00%
Sep 30, 2021 27.74%